Suchergebnisse - "Quek, Ruben G W"

PubPharm (71)

1

Aiding the Adoption of Master Protocols by Optimizing Patient Engagement

enthalten in: Therapeutic innovation & regulatory science | 2023

von Huml, R. | Collyar, D. | Antonijevic, Z. | +3

2

Aiding the Adoption of Master Protocols by Optimizing Patient Engagement

enthalten in: Therapeutic innovation & regulatory science | 2023

von Huml, R. | Collyar, D. | Antonijevic, Z. | +3

3

Regulatory and HTA Considerations for Development of Real-World Data Derived External Controls

enthalten in: Clinical pharmacology and therapeutics | 2023

von Curtis, L. | Sola-Morales, O. | Heidt, J. | +11

4

Effectively Leveraging RWD for External Controls : A Systematic Literature Review of Regulatory and HTA Decisions

enthalten in: Clinical pharmacology and therapeutics | 2023

von Sola-Morales, O. | Curtis, L. | Heidt, J. | +10

ErratumIn: Clin Pharmacol Ther. 2024 Feb 6;:. - PMID 38319048

5

Quality of life with cemiplimab plus chemotherapy for first-line treatment of advanced non-small cell lung cancer : Patient-reported outcomes from phase 3 EMPOWER-Lung 3

enthalten in: Cancer | 2023

von Makharadze, T. | Quek, R. | Melkadze, T. | +16

6

Cemiplimab Plus Chemotherapy Versus Chemotherapy Alone in Advanced NSCLC : 2-Year Follow-Up From the Phase 3 EMPOWER-Lung 3 Part 2 Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Makharadze, T. | Gogishvili, M. | Melkadze, T. | +17

CommentIn: J Thorac Oncol. 2023 Jul;18(7):e72-e73. - PMID 37348996

7

Regulatory and HTA Considerations for Development of Real‐World Data Derived External Controls

enthalten in: Clinical Pharmacology & Therapeutics | 2023

von Curtis, L. | Sola‐Morales, O. | Heidt, J. | +11

8

Effectively Leveraging RWD for External Controls : A Systematic Literature Review of Regulatory and HTA Decisions

enthalten in: Clinical Pharmacology & Therapeutics | 2023

von Sola‐Morales, O. | Curtis, L. | Heidt, J. | +10

9

Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer : a randomized, controlled, double-blind phase 3 trial

enthalten in: Nature medicine | 2022

von Gogishvili, M. | Melkadze, T. | Makharadze, T. | +23

10

Machine learning models for identifying predictors of clinical outcomes with first-line immune checkpoint inhibitor therapy in advanced non-small cell lung cancer

enthalten in: Scientific reports | 2022

von Li, Y. | Brendel, M. | Wu, N. | +7

1
2
3
4
5
6
7
8
Nächster »
[8]